Global Artificial Intelligence Eye Screening Software Market Research Report 2024

Publication ID:

PB504243361

Publication Date:

April 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
The global Artificial Intelligence Eye Screening Software market was valued at US$ 115 million in 2023 and is anticipated to reach US$ 8808 million by 2030, witnessing a CAGR of 84.0% during the forecast period 2024-2030.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy. It is estimated that vision-threatening diabetic retinopathy (vtDR) is present in around 22% of patients with diabetes, with clinically significant macular edema present in about 4% of patients, although the numbers can widely vary based on the population and access to care. Regardless of the exact numbers, there is no doubt that diabetic retinopathy remains a significant health burden and cause of visual loss. Early detection of diabetic retinopathy is key, because early treatment and lifestyle modifications can help prevent or minimize vision-threatening complications.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Eye Screening Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Eye Screening Software.
The Artificial Intelligence Eye Screening Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Eye Screening Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence Eye Screening Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Segment by Type
Diabetic Retinopathy (DR)
Age-Related Macular Degeneration (AMD)
Myopia
Others
Segment by Application
Medical Institutions
Great Health Scene
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence Eye Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Eye Screening Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diabetic Retinopathy (DR)
1.2.3 Age-Related Macular Degeneration (AMD)
1.2.4 Myopia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Artificial Intelligence Eye Screening Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Institutions
1.3.3 Great Health Scene
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Eye Screening Software Market Perspective (2019-2030)
2.2 Global Artificial Intelligence Eye Screening Software Growth Trends by Region
2.2.1 Global Artificial Intelligence Eye Screening Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence Eye Screening Software Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence Eye Screening Software Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence Eye Screening Software Market Dynamics
2.3.1 Artificial Intelligence Eye Screening Software Industry Trends
2.3.2 Artificial Intelligence Eye Screening Software Market Drivers
2.3.3 Artificial Intelligence Eye Screening Software Market Challenges
2.3.4 Artificial Intelligence Eye Screening Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Eye Screening Software Players by Revenue
3.1.1 Global Top Artificial Intelligence Eye Screening Software Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence Eye Screening Software Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Eye Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Artificial Intelligence Eye Screening Software Revenue
3.4 Global Artificial Intelligence Eye Screening Software Market Concentration Ratio
3.4.1 Global Artificial Intelligence Eye Screening Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Eye Screening Software Revenue in 2023
3.5 Global Key Players of Artificial Intelligence Eye Screening Software Head office and Area Served
3.6 Global Key Players of Artificial Intelligence Eye Screening Software, Product and Application
3.7 Global Key Players of Artificial Intelligence Eye Screening Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Eye Screening Software Breakdown Data by Type
4.1 Global Artificial Intelligence Eye Screening Software Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence Eye Screening Software Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence Eye Screening Software Breakdown Data by Application
5.1 Global Artificial Intelligence Eye Screening Software Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence Eye Screening Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence Eye Screening Software Market Size (2019-2030)
6.2 North America Artificial Intelligence Eye Screening Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence Eye Screening Software Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence Eye Screening Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Eye Screening Software Market Size (2019-2030)
7.2 Europe Artificial Intelligence Eye Screening Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence Eye Screening Software Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence Eye Screening Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence Eye Screening Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence Eye Screening Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Eye Screening Software Market Size (2019-2030)
9.2 Latin America Artificial Intelligence Eye Screening Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence Eye Screening Software Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence Eye Screening Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence Eye Screening Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Details
11.1.2 Airdoc Technology Business Overview
11.1.3 Airdoc Technology Artificial Intelligence Eye Screening Software Introduction
11.1.4 Airdoc Technology Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.1.5 Airdoc Technology Recent Development
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Details
11.2.2 Digital Diagnostics Business Overview
11.2.3 Digital Diagnostics Artificial Intelligence Eye Screening Software Introduction
11.2.4 Digital Diagnostics Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.2.5 Digital Diagnostics Recent Development
11.3 Eyenuk
11.3.1 Eyenuk Company Details
11.3.2 Eyenuk Business Overview
11.3.3 Eyenuk Artificial Intelligence Eye Screening Software Introduction
11.3.4 Eyenuk Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.3.5 Eyenuk Recent Development
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Details
11.4.2 RetinaLyze System Business Overview
11.4.3 RetinaLyze System Artificial Intelligence Eye Screening Software Introduction
11.4.4 RetinaLyze System Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.4.5 RetinaLyze System Recent Development
11.5 Optomed
11.5.1 Optomed Company Details
11.5.2 Optomed Business Overview
11.5.3 Optomed Artificial Intelligence Eye Screening Software Introduction
11.5.4 Optomed Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.5.5 Optomed Recent Development
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Details
11.6.2 Sibionics Technology Business Overview
11.6.3 Sibionics Technology Artificial Intelligence Eye Screening Software Introduction
11.6.4 Sibionics Technology Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.6.5 Sibionics Technology Recent Development
11.7 Aeye Health
11.7.1 Aeye Health Company Details
11.7.2 Aeye Health Business Overview
11.7.3 Aeye Health Artificial Intelligence Eye Screening Software Introduction
11.7.4 Aeye Health Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.7.5 Aeye Health Recent Development
11.8 VUNO
11.8.1 VUNO Company Details
11.8.2 VUNO Business Overview
11.8.3 VUNO Artificial Intelligence Eye Screening Software Introduction
11.8.4 VUNO Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.8.5 VUNO Recent Development
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Details
11.9.2 Medimaging Integrated Solution Business Overview
11.9.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening Software Introduction
11.9.4 Medimaging Integrated Solution Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.9.5 Medimaging Integrated Solution Recent Development
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Details
11.10.2 EyRIS (SELENA+) Business Overview
11.10.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening Software Introduction
11.10.4 EyRIS (SELENA+) Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.10.5 EyRIS (SELENA+) Recent Development
11.11 Vistel
11.11.1 Vistel Company Details
11.11.2 Vistel Business Overview
11.11.3 Vistel Artificial Intelligence Eye Screening Software Introduction
11.11.4 Vistel Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.11.5 Vistel Recent Development
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Details
11.12.2 RETINA-AI Health Business Overview
11.12.3 RETINA-AI Health Artificial Intelligence Eye Screening Software Introduction
11.12.4 RETINA-AI Health Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.12.5 RETINA-AI Health Recent Development
11.13 Acer Medical
11.13.1 Acer Medical Company Details
11.13.2 Acer Medical Business Overview
11.13.3 Acer Medical Artificial Intelligence Eye Screening Software Introduction
11.13.4 Acer Medical Revenue in Artificial Intelligence Eye Screening Software Business (2019-2024)
11.13.5 Acer Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂